Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Read-Out Ready Platform Improves Lab Procedures

By LabMedica International staff writers
Posted on 21 Aug 2012
One-step collection, transport, incubation, and observation devices offer a simple solution for point-of-care (POC) infectious disease diagnosis.

The InTray and InPouch devices combine sample collection, transport, and culture in a single read-out ready platform, thereby reducing handling, increasing productivity, improving throughput, and reducing the risk of sample exposure and contamination. More...


The InPouch product is an easy-to-use, fully enclosed oxygen-resistant plastic pouch for microbiology sample collection, transport, culture, and observation. Once the sample has been inoculated, the InPouch is sealed against contamination. The optically clear InPouch can be directly viewed under the microscope without the need to prepare a wet mount slide. InPouch offers a variety of media that deliver specificity and selectivity and it has a shelf life of up to one year. InPouch is also compatible for use with polymerase chain reaction (PCR).

The InTray product is a fully enclosed cassette for microbiology sample collection, transport, and culture. This stackable device can be observed under a microscope through optically clear plastic, eliminating the need to prepare a wet mount slide. The fully enclosed system features controlled air exchange to protect against exposure or contamination, and is ideal for field use or austere environments. InTray products featuring Colorex technology produce easy-to-interpret results that can be read visually via color changes in the sample.

BioMed Diagnostics, Inc., (White City, OR, USA), the manufacturer of these microbiology devices, announced that its InTray and InPouch product lines will now be available worldwide through a new agreement with VWR International (Radnor, PA, USA) a global laboratory supply and distribution company. Under the terms of the agreement, VWR will distribute BioMed’s products for the diagnosis of infectious disease.

Steve Goodman, senior vice president of category management for VWR said, “The initial response to these products has been excellent and we look forward to making them available globally to the many labs and facilities that can benefit from their use.”

Related Links:
BioMed Diagnostics, Inc.
VWR International



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.